Lineage Cell Therapeutics
LCTX
LCTX
74 hedge funds and large institutions have $99.9M invested in Lineage Cell Therapeutics in 2016 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 28 increasing their positions, 16 reducing their positions, and 3 closing their positions.
Holders
74
Holders Change
+8
Holders Change %
+12.12%
% of All Funds
1.98%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
11
Increased
28
Reduced
16
Closed
3
Calls
–
Puts
$241K
Net Calls
-$241K
Net Calls Change
+$633K
Top Buyers
Top Sellers
1 |
MHP
1
Manatuck Hill Partners
Westport,
Connecticut
|
$2.3M |
2 |
2
Jane Street
New York
|
$0 |
3 |
3
Citigroup
New York
|
$22K |
4 |
4
D.E. Shaw & Co
New York
|
$43K |
5 |
FM
5
Family Management
New York
|
$244K |